Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies

Urology

Volumn 53, Issue 5, 1999, Pages 1011-1018

  Montorsi, Francesco ^a   McDermott, T E D ^b   Morgan, Robert ^c   Olsson, Arne ^d   Schultz, Alexander ^e   Kirkeby, Hans Jorgen ^f   Osterloh, Ian H ^g  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f Kirurgisk Urologask Afdeling K   (Denmark)

^g PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FLUSHING; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; ORGASM; PENIS; PENIS ERECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SATISFACTION; SEXUAL DYSFUNCTION; SEXUAL INTERCOURSE;

ADMINISTRATION, ORAL; ADULT; AGED; DOUBLE-BLIND METHOD; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PIPERAZINES;

EID: 0033046143     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00643-8     Document Type: Article

References (27)

1. Impotence. JAMA. 270:1993;83-90.
2. Montague D.K., Barada J.H., Belker A.M., et al. Clinical guidelines panel on erectile dysfunction summary report on the treatment of organic erectile dysfunction . J Urol. 156:1996;2007-2011.
3. Kaiser F.E., Viosca S.P., Morley J.E., et al. Impotence and aging clinical and hormonal factors . J Am Geriatr Soc. 36:1988;511-519.
4. Morley J.E. Impotence. Am J Med. 80:1986;897-905.
5. Benet A.E., Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am. 22:1995;699-709.
6. Spector K.R., Boyle M. The prevalence and perceived aetiology of male sexual problems in a non-clinical sample. Br J Med Psychol. 59:1986;351-358.
7. Rubin A., Babbott D. Impotence in diabetes mellitus. JAMA. 168:1958;498-500.
8. McCulloch D.K., Campbell I.W., Wu F.C., et al. The prevalence of diabetic impotence. Diabetologia. 18:1980;279-283.
9. Abram H.S., Hester L.R., Sheridan W.F., et al. Sexual functioning in patients with chronic renal failure. J Nerv Ment Dis. 160:1975;220-226.
10. Cornely C.M., Schade R.R., Van Thiel D.H., et al. Chronic advanced liver disease and impotence cause and effect? Hepatology. 4:1984;1227-1230.
11. Gilling P.J., Wright W.L., Gray J.M. Factors associated with sexual dysfunction following transurethral resection of the prostate. N Z Med J. 101:1988;484-485.
12. Bors E., Comarr A.E. Neurological disturbances of sexual function with special reference to 529 patients with spinal cord injury. Urol Surv. 10:1960;191-222.
13. Slag M.F., Morley J.E., Elson M.K., et al. Impotence in medical clinic outpatients. JAMA. 249:1983;1736-1740.
14. Krane R.J., Goldstein I., Saenz de Tejada I. Impotence. N Engl J Med. 321:1989;1648-1659.
15. Feldman H.A., Goldstein I., Hatzichristou D.G., et al. Impotence and its medical and psychosocial correlates results of the Massachusetts Male Aging Study . J Urol. 151:1994;54-61.
16. Andersson K.-E., Wagner G. Physiology of penile erection. Physiol Rev. 75:1995;191-236.
17. Burnett A.L. Role of nitric oxide in the physiology of erection. Biol Reprod. 52:1995;485-489.
18. Burnett A.L. Nitric oxide in the penis physiology and pathology . J Urol. 157:1997;320-324.
19. Ignarro L.J., Lippton H., Edwards J.C., et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide evidence for the involvement of S-nitrosothiols as active intermediates . J Pharmacol Exp Ther. 218:1981;739-749.
20. Lugnier C., Komas N. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP role in vasodilatation . Eur Heart J. 14:(suppl 1):1993;141-148.
21. Boolell M., Allen M.J., Ballard S.A., et al. Sildenafil an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction . Int J Impot Res. 8:1996;47-52.
22. Boolell M., Gepi-Attee S., Gingell J.C., et al. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol. 78:1996;257-261.
23. Ogrinc F.G., Linet O.I. Evaluation of real-time Rigiscan monitoring in pharmacological erection. J Urol. 154:1995;1356-1359.
24. Andersen B.L., Broffitt B. Is there a reliable and valid self-report measure of sexual behavior? Arch Sex Behav. 17:1988;509-525.
25. Conte H.R. Development and use of self-report techniques for assessing sexual functioning a review and critique . Arch Sex Behav. 12:1983;555-576.
26. Rosen R.C., Riley A., Wagner G., et al. The International Index of Erectile Function (IIEF) a multidimensional scale for assessment of erectile dysfunction . Urology. 49:1997;822-830.
27. Gillespie P.G., Beavo J.A. Characterization of a bovine cone photoreceptor phosphodiesterase purified by cyclic GMP-sepharose chromatography. J Biol Chem. 263:1988;8133-8141.